« Back to Record
Citation APA

Ramanathan, R. R., Liu, H., McGovern, D., Lu, B., Von Hoff, D. D., Goldstein, D., Korn, R. R., Arena, F. F., Moore, M. J., Siena, S., Teixeira, L., Tabernero, J., & Van Laethem, J.-L. (2016). Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas. Annals of oncology, 27(4), mdw020, 648-653. doi:10.1093/annonc/mdw020


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/231472

Ramanathan, R. R., Liu, H., McGovern, D., Lu, B., Von Hoff, D. D., Goldstein, D., Korn, R. R., Arena, F. F., Moore, M. J., Siena, S., Teixeira, L., Tabernero, J., & Van Laethem, J.-L. (2016). Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas. Annals of oncology, 27(4), mdw020, 648-653. doi:10.1093/annonc/mdw020